Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abdel Salam Attia Ismail"'
Autor:
Jorge P. Leguizamo, Jean L. Grem, Chris H. Takimoto, Abdel Salam Attia Ismail, Janet Pang, Mary G. Quinn, Michael D. Liang, William L. Dahut
Publikováno v:
Cancer Chemotherapy and Pharmacology. 52:333-338
A phase I pharmacologic study was undertaken to determine the maximum tolerated dose (MTD), to characterize the pharmacokinetic profile, and to evaluate all toxicities of the aqueous colloidal dispersion formulation of 9-aminocampothecin (9-AC).9-AC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2c1aa5fdcc6bd155b6faa3fa6e6818
https://doi.org/10.1007/s00280-003-0657-1
https://doi.org/10.1007/s00280-003-0657-1
Autor:
Frank M. Balis, W. Corse, Chris H. Takimoto, David J. Liewehr, Mary Flanagan Quinn, Jean L. Grem, Robert F. Murphy, J M Hamilton, Carmen J. Allegra, Brian P. Monahan, Nancy Harold, Alice P. Chen, Janet Pang, Seth M. Steinberg, R. Lush, Abdel Salam Attia Ismail
Publikováno v:
Cancer Chemotherapy and Pharmacology. 47:117-125
Purpose: Clinical toxicity associated with 5-fluorouracil (5-FU) is related to the area under the plasma concentration-time curve (AUC). Recently, short-term infusions of 5-FU given over 30 or 60 min have been substituted for conventional "bolus" 5-F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f95c78225c9ae02d426e76afd3b2de8e
https://doi.org/10.1007/s002800000189
https://doi.org/10.1007/s002800000189
Autor:
Jean L. Grem, Aaron Ernst, Maurice A. Wright, Vivian Kao, Ilan R. Kirsch, Allison Parr, Liam Grogan, Abdel Salam Attia Ismail, Frank Grollman, Mary G. Quinn
Publikováno v:
Oncology Reports.
We have reported that increasing the length of infusion from 5 min to 1 h appeared to substantially reduce the toxicity associated with fluorouracil (5-FU) modulated by leucovorin (LV) and interferon alpha-2a (IFN-alpha). This phase II study assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::454c934812ff4ab9c715e3925d75de1d
https://doi.org/10.3892/or.13.6.1145
https://doi.org/10.3892/or.13.6.1145
Autor:
Abdel Salam Attia, Ismail, Mary G, Quinn, Maurice A, Wright, Aaron, Ernst, Vivian, Kao, Liam, Grogan, Allison, Parr, Frank, Grollman, Ilan R, Kirsch, Jean L, Grem
Publikováno v:
Oncology reports. 13(6)
We have reported that increasing the length of infusion from 5 min to 1 h appeared to substantially reduce the toxicity associated with fluorouracil (5-FU) modulated by leucovorin (LV) and interferon alpha-2a (IFN-alpha). This phase II study assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cd63def07ea94be79c5179186a0960dc
https://pubmed.ncbi.nlm.nih.gov/15870935
https://pubmed.ncbi.nlm.nih.gov/15870935
Autor:
Jeremy Shapiro, Roger A. Band, Nathan A. Berger, Carmen J. Allegra, Aida Guemei, Mary Flanagan Quinn, Susan G. Arbuck, J. Michael Hamilton, Abdel Salam Attia Ismail, Jean L. Grem, Jeff Cottrell, Alice P. Chen, Sosamma J. Berger, Nancy Harold, Donald Flemming, Haruyo Hirota, Victor Llorens, Geraldine Morrison, Chris H. Takimoto, Hilary Hehman, Brian P. Monahan, David Gosky, John J. Wright
Publikováno v:
Journal of Clinical Oncology. 18:659-659
PURPOSE: We conducted a phase I and pharmacologic study of a weekly 96-hour infusion of irinotecan to determine the maximum-tolerated dose, define the toxicity profile, and characterize the clinical pharmacology of irinotecan and its metabolites. PAT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2b99810c2fa0ee3359884bf3ce402cb
https://doi.org/10.1200/jco.2000.18.3.659
https://doi.org/10.1200/jco.2000.18.3.659